SequelSEC

Medinotec Inc. MDNC

Surgical & Medical Instruments & Apparatus · CIK 0001931055 · Fiscal year ends 0228

AnnualQuarterlyTTM
Revenue
$2.65M
Fiscal year ended 2026-05-31
Operating income
$180.87K
Fiscal year ended 2026-05-31
Free cash flow
-$216.48K
Fiscal year ended 2026-05-31

Medinotec Inc. (MDNC) reported revenue of $2.65M and net income of $222.01K for the fiscal year ended 2026-05-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Medinotec Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Medinotec Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-05-312026-02-282025-11-302025-08-312025-05-312025-02-282024-11-302024-08-312024-05-312024-02-29
Revenue$2.65M$1.82M$2.54M$3.24M$2.13M$3.53M$2.57M$1.80M$1.25M$2.25M
Cost of revenue$1.34M$967.58K$1.19M$1.23M$1.22M$1.18M$1.52M$970.61KUnavailable-$3.88M
Gross profit$1.31M$854.56K$1.35M$2.00M$913.17K$2.34M$1.04M$833.41KUnavailable$971.04K
Operating income$180.87K-$264.22K$552.71K$528.56K$277.46K$1.96M$527.45K$435.75K$269.17K$246.08K
Net income$222.01K-$69.26K$403.41K$346.57K$113.78K$1.48M$310.31K$284.75K$87.20K$98.56K
Research & development$7.97K$26.28K$8.33K$66.24K$49.01K$4.99K$69.27K$1.89K-$14.98K-$39.20K
Weighted-average diluted sharesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Pretax income$208.50K-$273.12K$542.71K$536.82K$262.77K$1.92M$481.47K$405.03K$214.14K$187.00K
Income tax expenseUnavailable-$753.23K$13.52K$193.94K$148.99K-$1.28M$148.99K$110.68K$126.94K-$213.40K
Diluted EPSUnavailableUnavailableUnavailable$0.03$0.01UnavailableUnavailable$0.02$0.01Unavailable
Selling, general & administrative$1.10M$1.03M$777.35K$1.40M$579.19K$362.70K$424.85K$376.25K-$298.21K-$2.82M
General & administrative$594.29K$586.78K$435.40K$725.47K$557.42K$338.59K$379.22K$353.81K-$277.21K-$2.62M
Selling & marketing$503.26K$447.51K$341.95K$674.40K$21.77K$24.11K$45.63K$22.44K-$21.01K-$196.42K

Balance

Medinotec Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-05-312026-02-282025-11-302025-08-312025-05-312025-02-282024-11-302024-08-312024-05-312024-02-29
Cash & equivalentsUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Total assets$6.99M$6.81M$6.85M$6.37M$7.40M$6.81M$5.36M$5.30M$4.32M$4.80M
Current assets$6.57M$6.42M$6.47M$5.98M$6.96M$6.42M$4.92M$4.90M$3.94M$4.38M
Total liabilities$1.13M$1.10M$1.35M$1.53M$3.04M$2.54M$2.54M$2.77M$2.07M$2.64M
Current liabilities$1.13M$1.10M$1.35M$1.53M$2.09M$1.51M$1.47M$1.57M$771.75K$827.45K
Total equity incl. NCI$5.85M$5.71M$5.50M$4.84M$4.37M$4.27M$2.83M$2.53M$2.25M$2.17M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$2.51M$2.35M$2.26M$2.58M$3.89M$2.61M$992.46K$771.37K$358.68K$589.76K
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

Medinotec Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-05-312026-02-282025-11-302025-08-312025-05-312025-02-282024-11-302024-08-312024-05-312024-02-29
Operating cash flow-$176.12K-$120.64K$563.14K$1.22M-$759.24K$98.72K$124.51K$408.43K$246.18K-$86.99K
Capital expenditures$40.35KUnavailableUnavailableUnavailableUnavailable-$1.35K$72.63K$23.79K-$6.06K-$1.40K
Investing cash flow-$40.35KUnavailableUnavailableUnavailableUnavailable$1.35K-$72.63K-$11.68K-$6.06K$10.98K
Financing cash flowUnavailable$25-$2.53K-$942.57K-$37.90K-$50.93K-$109.68K-$192.33K-$541.54K$274.46K
Net change in cash-$238.71K-$99.90K$608.83K$297.22K-$818.81K$93.16K-$81.80K$239.24K-$289.83K$130.16K
Stock-based compensationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$21.28K$58.20K$7.67K$7.50K$7.51K-$657$19.21K$19.52K$23.23K-$100.40K

Derived

Medinotec Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-05-312026-02-282025-11-302025-08-312025-05-312025-02-282024-11-302024-08-312024-05-312024-02-29
Free cash flow-$216.48KUnavailableUnavailableUnavailableUnavailableUnavailable$51.88K$384.64KUnavailableUnavailable
Gross margin49.3%46.9%53.1%61.9%42.8%66.5%40.6%46.2%Unavailable43.1%
Operating margin6.8%-14.5%21.8%16.3%13.0%55.6%20.6%24.2%21.5%10.9%
FCF margin-8.2%UnavailableUnavailableUnavailableUnavailableUnavailable2.0%21.3%UnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio5.81x5.83x4.79x3.90x3.33x4.27x3.34x3.13x5.10x5.29x
Revenue YoY growth24.2%-48.3%-1.1%79.4%70.5%56.6%28.1%414.3%200.8%706.1%
Net margin8.4%-3.8%15.9%10.7%5.3%41.9%12.1%15.8%7.0%4.4%
R&D / revenue0.3%1.4%0.3%2.0%2.3%0.1%2.7%0.1%-1.2%-1.7%
CapEx / revenue1.5%UnavailableUnavailableUnavailableUnavailable-0.0%2.8%1.3%-0.5%-0.1%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailable36.1%Unavailable-66.7%Unavailable27.3%59.3%-114.1%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MDNC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-09View SEC filing
10-K · Filed 2026-05-28View SEC filing
10-Q · Filed 2026-01-09View SEC filing
10-Q · Filed 2025-10-08View SEC filing
10-Q · Filed 2025-07-16View SEC filing
10-K · Filed 2025-05-29View SEC filing

Companies in the same industry

Reconciliation checks needing review

3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2024-05-31

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2023-05-31

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2022-09-30

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.